Hsbc Holdings PLC Medicinova Inc Transaction History

Hsbc Holdings PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$3.4 - $4.24 $46,355 - $57,808	-13,634 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.76 - $5.14 $37 - $51	10 Added 0.07%	13,634 $57,000
Q1 2021 May 14, 2021	SELL	$4.81 - $8.74 $28,595 - $51,959	-5,945 Reduced 30.38%	13,624 $68,000
Q4 2020 Feb 25, 2021	BUY	$5.03 - $6.31 $5,080 - $6,373	1,010 Added 5.44%	19,569 $102,000
Q2 2020 Aug 14, 2020	BUY	$3.06 - $7.06 $56,790 - $131,026	18,559 New	18,559 $101,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $98.1M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.